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E-mail address: lssqlh@mail.sysu.edu.cn (L.-H. Qu)Deposition of collagen IV in proximal tubule cells (PTCs) plays an important role during diabetic
nephropathy, but the mechanism underlying excessive production of collagen IV remains poorly
understood. In this study, we examined the miRNA proﬁle of HK-2 cells and found that high glu-
cose/TGF-b1 induced signiﬁcant down-regulation of miR-29a. We then showed that miR-29a nega-
tively regulated collagen IV by directly targeting the 30UTRs of col4a1 and col4a2. These results
suggest that miR-29a acts as a repressor to ﬁne-tune collagen expression and that the reduction
of miR-29a caused by high glucose may increase the risk of excess collagen deposition in PTCs.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Diabetic nephropathy (DN) is a serious complication of diabetes
and is the most common cause of kidney failure in diabetic pa-
tients. Studies have shown that the pathogenesis of DN is attribut-
able to hyperglycemia-activated downstream pathways, among
which transforming growth factor b1 (TGF-b1) plays the most
important role [1,2]. Both in vitro and in vivo studies have demon-
strated that elevated glucose levels activate TGF-b1 and subse-
quently increase the production of collagen IV in proximal tubule
cells (PTCs) [3–5]. Excessive collagen IV-induced basement mem-
brane thickening underlies the critical morphological characteris-
tics of tubulointerstitial injury in DN [3]. However, the molecular
mechanism by which collagen IV is induced by high glucose re-
mains poorly understood.
MicroRNAs (miRNAs), which are short (22 nt) non-coding
RNAs, have been shown to play key roles in diverse biological and
pathological processes [6]. Recently, several studies have demon-
strated that dysregulation ofmiRNAs is linked to hyperglycemia-in-
duced DN. For example, miR-192 is involved in TGF-b1-mediated
collagen I and III synthesis [7], and up-regulated miR-377 increases
ﬁbronectin production in DN [8]. However, these studies focused on
glomerular mesangial cells (GMCs), not PTCs. In fact, PTCs consti-chemical Societies. Published by E
esearch Center, Sun Yat-sen
84036551.
.tute the bulk of the renal cortical cells, and their central role in tub-
ulointerstitial injury in DN has been extensively studied [9,10]. So
far, however, the expression and function of miRNAs in PTCs during
DN have not been reported. Thus, further investigation of miRNA
regulation in PTCs is essential to unravel themolecularmechanisms
underpinning tubulointerstitial changes in DN.
In this study, we determined the miRNA expression proﬁle of a
cell line derived from human PTCs (HK-2 cells), and we found that
high glucose/TGF-b1 induced signiﬁcant down-regulation of miR-
29a. We further validated that miR-29a negatively regulated colla-
gen IV protein by directly targeting the 30UTRs of collagen IV tran-
scripts. The results suggest that miR-29a acts as a repressor to ﬁne-
tune collagen expression and accumulation in HK-2 cells.
2. Materials and methods
2.1. Cell culture
The proximal tubule cell line HK-2 was purchased from the cell
culture center of the Chinese Academy of Medical Sciences. Cells
were maintained in Dulbecco’s modiﬁed Eagle’s medium (DMEM)
supplemented with 5 mM glucose, 10% heat-inactivated FBS,
100 IU/ml penicillin and 100 mg/ml streptomycin (Gibco/Life
Technologies, Paisley, UK) and incubated at 37 C in a humidiﬁed
incubator with 5% CO2.
Subconﬂuent HK-2 cells were seeded at a 10% density on 10-cm
Petri dishes and maintained in medium containing 5 mM D-glucoselsevier B.V. All rights reserved.
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ged every two days to maintain glucose levels in the desired range.
For the TGF-b1 assay, 3  105 cells were planted in each well of a 6-
well plate. Experiments were performed after cells were cultured
in medium containing low serum (2% FBS) and 10 ng/ml TGF-b1
(PeproTech, Rocky Hill, NJ, USA) for 72 h.
2.2. MiRNA microarray
RNA from HK-2 cells treated with NG or HG was used for miR-
NA microarray analysis. Microarray procedures and data analysis
were performed at Beijing CapitalBio Corporation as described
previously [11]. Brieﬂy, total RNA extracted from HK-2 cells trea-
ted with NG or HG was covalently labeled with Cy3 (green chan-
nel) or Cy5 (red channel), respectively. Dye switching was done to
eliminate dye bias. Pairs of labeled samples were hybridized to
dual-channel microarrays. Fluorescence scanning used a double-
channel laser scanner. The analog signal was transformed to a
digital signal using image analysis software. Signal intensities
for each spot were calculated by subtracting local background
from total intensity. Raw data were normalized and analyzed
using the Signiﬁcance Analysis of Microarrays (SAM, Stanford
University, CA, USA) software.
2.3. Quantitative real-time polymerase chain reaction
Total RNA was extracted from cells and samples were reverse-
transcribed to cDNA using the primescript™ RT reagent kit (Takara,
Tokyo, Japan). Real-time PCR was carried out using SYBR Premix
ExTaq™ (Takara) according to manufacturer’s instructions. The in-
put was normalized by U6 snRNA. Hsa-miR-29a and U6 primer sets
were purchased from RiBiBio Corporation (Guangzhou, China).
Experiments were performed in triplicate, and the results are rep-
resented as mean ± S.E.M.
2.4. Northern blot analysis
Total RNA was extracted from HK-2 cells at indicated days using
TRIzol (Invitrogen, Carlsbad, CA, USA). Low molecular weight RNA
was subsequently isolated by precipitation in PEG8000/NaCl as
previously described [12]. Forty micrograms of low molecular
weight RNA was run on a denaturing 10% polyacrylamide gel,
transferred to PVDF membrane (Amersham/GE Healthcare, Piscat-
away, NJ, USA), subjected to UV light irradiation for 4 min and
baked at 80 C for 50 min. The hsa-miR29a oligonucleotide probe
(50-TAACCGATTTCAGATGGTGCTA-30) was 50 end-labeled with
[c-32P] ATP. The membranes were pre-hybridized for at least 1 h,
then hybridized overnight at 42 C. After three washes (2  SSC,
0.5% SDS), membranes were exposed to a phosphor screen and
visualized by Typhoon 8600 imager (Amersham). tRNAThr was used
as a loading control.
2.5. Luciferase reporter assays
For construction of reporter plasmids, synthesized 54-bp DNA
oligonucleotides containing the putative binding sites for miR-
29a in the 30UTR of col4a1 or col4a2 were annealed and cloned into
EcoRI/BglII-digested phRL-null (Promega, Madison, WI). The col4a1
and col4a2 30UTR target sites were cloned using the following oli-
gonucleotides: col4a1-site1: sense, AATTCTGAAGCCTGACTCAGC
TAATGTCACAACATGGTGCTACTTCTTCTA and antisense, GATCTAGA
AGAAGTAGCACCATGTTGTGACATTAGCTGAGTCAGGCTTCAG; col4a1-
site2: sense, AATTCTGTGAAGTGAGAACTCCATCAGAAAACCAAAGG
GTGCTAGGAGGTGTA and antisense, GATCTACACCTCCTAGCACCC
TTTGGTTTTCTGATGGAGTTCTCACTTCACAG; col4a2: sense, AATT
CGCCGGCGCGTGCCAGGAAGGGCCATTTTGGTGCTTATTCTTAA andantisense, GATCTTAAGAATAAGCACCAAAATGGCCCTTCCTGGCACG
CGCCGGCG. As a negative control response element, we used a mu-
tated sequence (underline) by inserting the following oligonucleo-
tides: col4a1-site1 MUT: sense, AATTCTGAAGCCTGACTCAGCTA
ATGTCACAACATAATTATACTTCTTCTA and antisense, GATCTAGAA
GAAGTATAATTATGTTGTGACATTAGCTGAGTCAGGCTTCAG; col4a1-
site2 MUT: sense, AATTCTGTGAAGTGAGAACTCCATCAGAAAACC
AAAGAATTATAGGAGGTGTA and antisense, GATCTACACCTCCTA
TAATTCTTTGGTTTTCTGATGGAGTTCTCACTTCACAG; col4a2 MUT:
sense, AATTCGCCGGCGCGTGCCAGGAAGGGCCATTTTAATTATTATT
CTTAA and antisense, GATCTTAAGAATAATAATTAAAATGGCCCTT
CCTGGCACGCGCCGGCG. HK-2 cells were plated in 48-well plates
and co-transfected with 0.1 lg of the phRL-null reporter plasmid
and 30 nM miR-29a or miR-neg mimic (Genepharma, Shanghai,
China) in each well using Lipofectamine 2000 (Invitrogen). Lucifer-
ase assays were performed 48 h after transfection using the Dual-
Luciferase Reporter Assay System (Promega) on a GloMax™ 96
Microplate Luminometer (Promega). Renilla luciferase activity
was normalized to ﬁreﬂy luciferase expression for each sample.
2.6. Transient transfection of miRNA mimic or anti-miR miRNA
inhibitors
HK-2 cells were seeded in 24-well plates at 105 cells/well. After
24 h, 50 nM hsa-miR-29a mimic or negative control (miR-neg) and
the indicated amounts of anti-miR-29a or control anti-miR (Gene-
pharma) were transiently transfected into HK-2 cells by Lipofect-
amine 2000 (Invitrogen). Seventy-two hours after transfection,
cell extracts were used for real-time PCR or western blot.
2.7. Western blot analysis
Collagen IV protein was analyzed by western blotting from total
cell lysates as described previously [13]. Proteins were extracted
with RIPA lysis buffer. Collagen IV protein was revealed with a col-
lagen IV polyclonal antibody (Abcam, Cambridge, MA, USA). Signals
were detected by Super signal Western Pico chemiluminescent
substrate (Pierce, Rockford, IL, USA). Western blotting of tubulin
on the same membrane was used as a loading control.
2.8. Statistics assay
Results are expressed as arbitrary units and are presented as the
mean ± S.E.M. In each experiment, all determinations were per-
formed at least in triplicate. Statistical signiﬁcance was assessed
using Student’s t test for experiments with multiple groups. Differ-
ences were considered signiﬁcant if P < 0.05.3. Results
3.1. Expression proﬁling of miRNAs in PTCs
To investigate whether miRNAs are involved in the pathogene-
sis of DN, it is essential to ﬁrst establish the miRNA expression pro-
ﬁle in PTCs. Therefore, we determined the miRNA expression
proﬁle of a common proximal tubule cell line, HK-2 cells, using
an established microarray platform. The microarray data revealed
that there were about 100 miRNAs for which the signal intensity
was more than 1500. Among these miRNAs, the miR-30 family
members, miR-565 and miR-21 were the most highly expressed
in HK-2 cells. According to the expression level, the 40 most highly
expressed miRNAs in HK-2 cells were arranged and shown in Fig. 1.
Generally, the miRNA expression level correlates with functional
importance, so dysregulation of some of these 40 miRNAs is per-
haps involved in PTC dysfunction during DN. Intriguingly, several
Fig. 1. MiRNA expression proﬁle of HK-2 cells. MiRNAs are ranked from left to right on the basis of their expression level.
Fig. 2. Down-regulation of miR-29a by HG or TGF-b1 in HK-2 cells. (A) Detection of miRNAs by dual-channel microarray. Part of the microarray image showed that there were
signiﬁcant differences in miR-29a levels between NG- and HG- treated HK-2 cells. The upper panel, total RNA extracted from NG- and HG- treated HK-2 cells was covalently
labeled with Cy3 (green channel) and Cy5 (red channel), respectively, and hybridized to the array. The lower panel, the RNA of NG- and HG- treated HK-2 cells labeled with
Cy5 and Cy3 dye, reversely. (B and C) MiR-29a was down-regulated by HG. Real-time PCR (B) and northern blotting (C) were performed to detect miR-29a in HK-2 cells
treated with NG or HG for seven days and normalized to U6 snRNA or tRNAThr, respectively. (D) MiR-29a was down-regulated by TGF-b1 treatment. Real-time PCR analysis of
miR-29a in TGF-b1-stimulated HK-2 cells at different days and normalized to U6 snRNA. All data represent the means of three independent experiments ± S.E.M. with n = 3.
**P < 0.01.
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did not appear in this list, implying different miRNA proﬁles for
PTCs and GMCs.
3.2. MiR-29a is down-regulated in response to high glucose or TGF-b1
stimulation in HK-2 cells
To determine whether miRNAs are involved in PTC regulation
during DN, we compared the HK-2 miRNA proﬁle after treatmentwith high glucose (HG) for seven days with that of cells exposed
to normal glucose (NG) by dual-channel miRNA microarrays. The
SAM (Signiﬁcance Analysis of Microarrays) results showed that
there were 14 miRNAs down or up-regulated more than 30% upon
HG treatment (Table 1). Among these miRNAs, we focused on miR-
29a, which showed the greatest fold change and was one of the 40
highly expressed miRNAs in HK-2 cells. As shown in Fig. 2A, the
dual-channel miRNA microarray images reveal the signiﬁcant dif-
ference in miR-29a expression between NG and HG treatments.
Table 1
Differentially expressed miRNAs in HK-2 cells treated with NG or HG.
Gene name Fold change Score Regulation
Hsa-miR-29a 0.113 12.663 Down
Hsa-miR-29c 0.445 18.826 Down
Hsa-miR-195 0.556 3.843 Down
Hsa-miR-532-5p 0.599 3.109 Down
Hsa-miR-923 0.623 2.305 Down
Hsa-miR-29b 0.637 12.233 Down
Hsa-miR-16 0.668 4.685 Down
Hsa-miR-362-3p 0.692 2.172 Down
Hsa-miR-374b 0.694 8.845 Down
Hsa-miR-596 1.304 3.165 Up
Hsa-miR-296-5p 1.339 6.601 Up
Hsa-miR-523 1.342 4.969 Up
Hsa-miR-760 1.390 3.154 Up
Hsa-miR-298 1.458 3.880 Up
The expressions of miRNAs were detected by miRNA microarray and SAM was used
for data analysis.
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expression of miR-29a in NG and HG-induced HK-2 cells. Consis-
tent with the microarray analysis, real-time PCR showed that the
miR-29a expression level fell by 40–50% (P < 0.01) when cells were
stimulated with HG for seven days (Fig. 2B). Northern blot analysis
revealed a similar pattern (Fig. 2C). Taken together, these results
conﬁrm that miR-29a is signiﬁcantly down-regulated by HG.Fig. 3. MiR-29a regulates collagen IV in HK-2 cells. (A) HG induced collagen IV expres
different durations using antibodies against collagen IV or tubulin. (B) Anti-miR-29a incre
transfected with 200 or 400 nM anti-miR-29a, anti-miR-neg or mock to determine the
tubulin using protein extracts from HK-2 cells transfected with 200 or 400 nM anti-miR
protein expression. Real-time PCR for mature miR-29a in HK-2 cells transfected with miR
panel). Western blots for collagen IV or tubulin using protein extracts from HK-2 cells tra
panel). Data represent three independent experiments ± S.E.M. with n = 3. **P < 0.01.It was previously shown that long-term exposure of PTCs to
high glucose induced TGF-b1 synthesis, whereas TGF-b1 knockout
attenuated collagen IV biosynthesis in PTCs [2]. Thus, we presumed
that TGF-b1 was involved in the down-regulation of miR-29a in
HG-treated HK-2 cells. To conﬁrm this, miR-29a levels were exam-
ined by real-time PCR after HK-2 cells were treated with TGF-b1 for
1, 2 or 3 days. Our data showed that miR-29a expression was also
reduced in TGF-b1-treated HK-2 cells (Fig. 2D), conﬁrming that
miR29a is down-regulated by HG/TGF-b1 pathway in HK-2 cells.
3.3. MiR-29a down-regulates collagen IV protein in HK-2 cells
The striking down-regulation of miR-29a in HK-2 cells after ele-
vation of the glucose concentration suggested that miR-29a might
participate in the dysfunction of PTCs treated with HG. Previous re-
ports indicated that the miR-29 family regulated the expression of
collagen I or III in metastasis, myocardial ﬁbrosis, and osteoblast
differentiation [14–16]. As increased production of collagen IV in
PTCs is an important pathological change during DN progression,
we presumed that the down-regulation of miR-29a might promote
the production of collagen IV in these cells. A series of functional
studies were performed to determine the role of miR-29a in the
regulation of collagen IV. First, we conﬁrmed by western blot that
high glucose induced the expression of collagen IV in HK-2 cells. As
shown in Fig. 3A, collagen IV protein in HK-2 cells gradually in-sion. Western blot of protein extracts from HK-2 cells treated with NG or HG for
ased collagen IV protein expression. Real-time PCR for mature miR-29a in HK-2 cells
knockdown efﬁciency of anti-miR-29a (left panel). Western blots for collagen IV or
-29a, anti-miR-neg or mock (right panel). (C) MiR-29a mimic decreased collagen IV
-29a mimic, miR-neg or mock to determine the efﬁciency of the miR-29a mimic (left
nsfected with miR-29a mimic, miR-neg or mock in HK-2 cells treated with HG (right
Fig. 4. MiR-29a directly targets col4a1 and col4a2. (A) Sequence alignment between miR-29a and predicted binding sites in the 3’UTR of col4a1 and col4a2 for human, mouse
and rat. (B) HK-2 cells were transfected with luciferase expression plasmids containing col4a1 or col4a2 3’UTRs with the predicted miR-29a target site or plasmids containing
a mutated sequence. The cells were also treated with either miR-29a mimic or negative mimic. Forty-eight hours after transfection, cells were assayed for ﬁreﬂy luciferase
and Renilla luciferase. Data represent three independent experiments ± S.E.M. with n = 3. *P < 0.05; **p < 0.01.
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lation between the expression of miR-29a and collagen IV in HK-2
cells after seven days of HG induction.
Next, we determined whether transfection of miR-29a or anti-
miR-29a affected collagen IV protein expression. A scrambled se-
quence (anti-miR-neg) was transfected as a negative control, and
the knockdown efﬁciency of anti-miR-29a was conﬁrmed by
real-time PCR (Fig. 3B, left panel). Down-regulation of endogenous
miR-29a with anti-miR-29a signiﬁcantly induced collagen IV pro-
tein (Fig. 3B, right panel). In addition, we compared results of
two different dose levels and observed that anti-miR-29a may in-
creased collagen IV protein in a dose-dependent manner.
To determine whether overexpression of miR-29a has the oppo-
site effect on collagen IV protein, HK-2 cells were transfected with
double-stranded RNA oligonucleotides containing the mature miR-
29a sequence (miR-29a mimic) or control miRNAs (miR-neg). Real-
time PCR results showed that, compared with miR-neg, miR-29a
mimic increased mature miR-29a levels by 100-fold, conﬁrming
the efﬁciency of the mimic (Fig. 3C, left panel). We then treated
HK-2 cells with this miR-29 mimic and found that it signiﬁcantly
decreased the collagen IV protein level (Fig. 3C, right panel). These
data suggest that miR-29a acts as a repressor to regulate collagen
IV protein expression level in HK-2 cells.
3.4. Col4a1 and col4a2 are directly targeted by miR-29a
The above results suggest that collagen IV is regulated by
miR-29a in PTCs. However, this regulation could be indirect. To
investigate whether miR-29a directly targets col4a1 and col4a2
(the two main subunits of collagen IV in PTCs), we screened
the 30UTR of col4a1 and col4a2 for complementarity to seed se-
quences of miR-29a via TargetScan software (www.target-
scan.org) and found that miR-29a has two putative target sitesin the 30UTR of col4a1 (position 29–35 nt and 307–313 nt) and
one site in the 30UTR of col4a2 (position 28–34 nt, Fig. 4A). More-
over, these target site sequences are highly conserved among hu-
man, mouse and rat, suggesting that miR-29a may act as a direct
regulator of collagen IV.
To test whether the putative miR-29a target sequences in the
col4a1 and col4a2 30UTRs directly regulate gene expression, we
constructed six luciferase expression plasmids containing the pre-
dicted miR-29a target sites in the col4a1 or col4a2 30UTRs or mu-
tated seed region sequences, named col4a1-site1/Mut-col4al-
site1, col4a1-site2/Mut-col4al-site2 and col4a2/Mut-col4a2, respec-
tively. MiR-29a mimic was co-transfected with these reporters into
HK-2 cells. As shown in Fig. 4B, compared with the miRNA negative
mimic, transfection of the miR-29a mimic decreased the luciferase
activity of col4a1-site1, col4a1-site2 and col4a2 by 40.5%, 41.9% and
47.4%, whereas the mutant sequence restored levels to 66.4%,
64.0% and 77.8%, respectively. Taken together, our data demon-
strate that miR-29a can directly regulate col4a1 and col4a2 through
their 30UTRs.
4. Discussion
The two main cell types in the renal cortex, GMCs and PTCs, are
both linked to hyperglycemia-induced DN [1,3]. Previous studies
found that up-regulation of miR-192 [7] and miR-377 [8] in GMCs
contributed to the accumulation of extracellular matrix (ECM) pro-
teins. Recently, a new study reported that miR-216a and miR-217
suppressed PTEN to activate Akt, which led to glomerular mesan-
gial expansion and hypertrophy [17]. However, it was not clear
whether these miRNAs were involved in PTC dysfunction during
DN. Through a miRNA array approach, we determined the PTC
miRNA expression proﬁle and found that it was quite different
from that of GMCs. For example, several miRNAs, including
Fig. 5. A model for the role of miR-29a in the collagen IV increase induced by high
glucose. In response to high glucose, TGF-b1 is activated [2] and triggers the down-
regulation of miR-29a in PTCs. Consequently, collagen IV is up-regulated and
contributes to tubulointerstitial ﬁbrosis and DN.
816 B. Du et al. / FEBS Letters 584 (2010) 811–816miR-192 and miR-215, that were highly expressed in GMCs were
almost undetectable in PTCs. Our data also revealed that miR-29a
negatively regulates the expression level of collagen IV in PTCs,
although it was not reported to be expressed in GMCs. These differ-
ences imply that miRNAs modulate the pathogenesis of DN in a cell
type-speciﬁc manner.
Our array showed that more than 100 miRNAs can be detected
in HK-2 cells, with the majority in very low abundance. Among the
40 most highly expressed miRNAs in HK-2, the expression level of
miR-29a was present at medium, compared with more highly ex-
pressed miRNAs such as miR-30a and miR-21 (Fig. 1). Recent stud-
ies revealed that miRNAs regulated their targets in different
patterns. In some cases, they seem to act as rheostats or ‘‘dimmer
switches” to ﬁne-tune the expression of target mRNAs [18],
whereas in other cases they function as ‘‘on–off” switches [19].
Medium-level miRNAs like miR-29a in HK-2 cells often fall into
the former category and co-exist with their targets (such as colla-
gen IV) in the same cells. Under normal serum glucose, miR-29a
expression maintains the physiological expression level of collagen
IV in PTCs. After high glucose induction, miR-29a is down-regu-
lated, permitting signiﬁcant changes in collagen IV deposition in
the long-term, and eventually leading to DN. In fact, many studies
have revealed that miRNAs ﬁne-tune key proteins to affect physi-
ological or pathological processes [20] such as cardiogenesis [21],
innate immune response [22] and hematopoietic differentiation
[23]. Thus, ﬁne-scale adjustments to target output by medium-ex-
pressed miRNAs may be a universal mechanism for regulating gene
expression, especially in long-term processes of biochemical
metabolism.
In summary, our studies revealed a new pathway for spatiotem-
poral control of collagen IV in PTCs during DN progression: high
levels of glucose stimulate TGF-b1 synthesis and subsequently de-
crease the expression of miR-29a, and this elevates the level of col-
lagen IV, which in turn mediates the pathogenesis of DN. A model
depicting this new pathway is shown in Fig. 5.
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